Swept Source OCT Imaging With the DREAM VG-OCT

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05876689

Enrollment

154

Registered

2023-05-25

Start date

2023-10-09

Completion date

2024-10-01

Last updated

2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases, Glaucoma, Myopia

Brief summary

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Interventions

DEVICEDREAM OCT

Swept Source OCT (similar to Zeiss Plex Elite)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Age greater than or equal to 18 * Myopes with a current or previously documented spherical equivalent refraction \< -4D * At least half of the subjects should have had at least one Cirrus OCT RNFL and macula performed as well as a Humphrey visual field performed in those with OCT abnormalities

Exclusion criteria

* Unable to comply with study imaging * unclear ocular media * Participant has, in the opinion of the investigator, any physical or mental condition that would affect the participation in the study or may interfere with the study procedures, evaluations and outcome assessments.

Design outcomes

Primary

Measure	Time frame	Description
Assessing difference in intraocular structures	Baseline	Assessing the performance of the DREAM VG OCT scan patterns in high myopes including glaucomatous eyes to see if there are differences in the lamina cribrosa structure when compared to patients previous Cirrus OCTs.
Assessing difference in intraocular vascular structures	Baseline	Assessing differences in vascular density in areas with presumed myopic-related field defects vs. low tension glaucoma perimetric disease

Secondary

Measure	Time frame	Description
Assessing repeatability of scans	Baseline	Analyze the repeatability of quantitative RNFL and GCC parameters.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026